FTXH
First Trust Nasdaq Pharmaceuticals ETF
1 year +45.5%Assets$1.13BFirst Trust
Fee0.57%a year
Yield0.7%NA
This year+29.5%
5 years+12.2%a year on average
Components50top 10: 55%
Returns
This year
+29.5%
1 year
+45.5%
3 years, yearly
+21.7%
5 years, yearly
+12.2%
10 years, yearly
+10.2%
The fund's own total return. Volatility 13.6% over one year, 14.1% over three; Sharpe ratio over three years 0.96.
Sectors
Healthcare100.0%
Regions
North America101.0%
United Kingdom0.5%
Asset classes
Stock US102.0%
Stock non-US0.5%
Cash0.1%
About the fund
- Issuer
- First Trust
- Since
- 2016-09-20
- Listed on
- NASDAQ
- ISIN
- US33738R8372
- Turnover
- 72% a year
The fund will normally invest at least 80% of its net assets (including investment borrowings) in the securities that comprise the index. The index is designed to provide exposure to U.S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking. It is non-diversified.
From the market data provider's fund data, read 2026-10-23. Returns are the fund's own; past returns say nothing certain about future ones. None of this is advice.